Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Central de Asturias (18)

2024

  1. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  3. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  2. Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis: A large-cohort study

    Biomedicines, Vol. 9, Núm. 8

  3. Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: The role of eosinophils in disease severity

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16

  4. RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 28-35

2020

  1. Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32

  2. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2018

  1. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  2. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882